[Protection of the cardiovascular system by estrogens. Role of the renin-angiotensin system].

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Deutsche Medizinische Wochenschrift

• Publication date

  2000-11-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2000-8494PMID 11130124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of ethinyl estradiol on renin activity and on the concentrations of renin substrate and aldosterone in plasma of ovariectomized women

  2005cited by this paper
• Use of Hormone Replacement Therapy by Postmenopausal Women in the United States

  1999cited by this paper
• Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen.

  1999cited by this paper
• Treatment of high blood pressure in Germany.

  1998cited by this paper
• Estrogen modulates AT1 receptor gene expression in vitro and in vivo.

  1998cited by this paper
• Salt induces vascular AT1 receptor overexpression in vitro and in vivo.

  1998cited by this paper
• Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury.

  1998cited by this paper
• Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

  1998cited by this paper
• Oestrogen and progesterone inhibit the stimulated production of endothelin-1.

  1998cited by this paper
• Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms.

  1998cited by this paper
• Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women.

  1998cited by this paper
• [Nitric oxide as a signal molecule in the cardiovascular system. Nobel Prize for Medicine in 1998].

  1998cited by this paper
• Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.

  1997cited by this paper
• Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women.

  1997cited by this paper
• Cardiac myocytes and fibroblasts contain functional estrogen receptors 1

  1997cited by this paper
• Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.

  1997cited by this paper
• Myocardial Infarction and the Use of Estrogen and Estrogen-Progestogen in Postmenopausal Women

  1997cited by this paper
• Effects of moexiprilat on oestrogen‐stimulated cardiac fibroblast growth

  1997cited by this paper
• Efficacy and tolerance of antihypertensive treatment in men and women with stage 1 diastolic hypertension. Results of the Treatment of Mild Hypertension Study.

  1996cited by this paper
• Hypertension and other cardiovascular risk factors in women.

  1995cited by this paper
• Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors

  1995cited by this paper
• Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression.

  1994cited by this paper
• Human vascular smooth muscle cells contain functional estrogen receptor.

  1994cited by this paper
• Molecular Biology of the Renin‐Angiotensin System

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Cardiovascular health and disease in women.

  1993cited by this paper
• A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women.

  1993cited by this paper
• Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

  1993cited by this paper
• Angiotensin II receptors and angiotensin II receptor antagonists.

  1993cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Hormone replacement therapy and cardiovascular disease.

  1992cited by this paper
• Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women.

  1992cited by this paper
• Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor

  1991cited by this paper
• Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor

  1991cited by this paper
• Menopause and the risk of coronary heart disease in women.

  1987cited by this paper
• Estrogens as natural antioxidants of membrane phospholipid peroxidation

  1987cited by this paper
• The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure.

  1987cited by this paper
• Menopausal estrogen use, high density lipoprotein cholesterol subfractions and liver function.

  1983cited by this paper
• The effect of estriol succinate therapy on plasma renin activity and urinary aldosterone in postmenopausal women.

  1978cited by this paper

• Gender differences in developmental programming of cardiovascular diseases.

  2016cites this paper
• Estrogen Protects Against Increased Blood Pressure in Postpubertal Female Growth Restricted Offspring

  2007cites this paper